Potential conflict of interest
Disclosure forms provided by the authors are available with the full text of this article at http://dx.doi.org/10.1080/10428194.2016.1180684.
Funding information
This work was funded by CIHR operating grant [MOP-12863] and the Samuel Waxman Cancer Research Foundation (WHM). The Q-CROC2 clinical trial was financed by Novartis and Roche. DDR is supported by the Cole foundation. LC is the Raymond and Beverly Sackler Scholar and Scholar of the American Society of Hematology. This work was supported by Doris Duke Charitable Foundation Grant [2012070] and the Irma T. Hirschl Career Scientist Award (LC).